News tagged with 'Incontinence'

Amber Suriani liked what she heard. Turning 40 and suffering the inconvenience of a light case of urinary incontinence, she liked hearing there was a quick fix – a sling would be placed under her urethra and she would be back to practicing karate the same week. Instead she's filing suit.

Lana Keeton's near death experience with synthetic surgical mesh has transformed her into a powerful online patient advocate.  With a chorus of others, Truth in Medicine is working to urge Congress to remove the medical device from the market. Already the group has generated an FDA notice warning of 1,000 adverse events and 10 deaths due to mesh.

About 13 million American women experience stress urinary incontinence and the Ethicon TVT vaginal mesh is the gold standard for treatment. While the company reports an 84 to 95 percent success rate, doctors who deal with mesh complications say the number of problems appear to be vastly underreported and a national registry is needed now. 

If you assumed that a medical device that's implanted to help hold up internal organs passed some safety review by the FDA, you'd be wrong.  Synthetic surgical mesh was approved for marketing only. Some in the medical profession suspect there's a problem - some women and men know there is.  

While the complication rate is said to be one in a million, a growing voice of patients claim that the medical device - synthetic surgical mesh - used to treat incontinence and hernias, is not staying put but is migrating, wrapping around organs, requiring repeated surgeries, and in some cases killing patients. They want it off the market. 

Vaginal mesh surgery sounded like a good idea to correct urinary incontinence that comes from childbirth, but so far there are at least 32 lawsuits filed against Mentor's ObTape and more are in the pipeline. The FDA reports 1,000 adverse reports from manufacturers concerning complications.

The U.S. Food and Drug Administration (FDA) has approved Toviaz, extended relief tablets - a new prescription drug to treat overactive bladder (OAB), a bothersome medical condition affecting more than one in six Americans.

In January 1999, Boston Scientific Corporation recalled the ProteGen Vaginal Sling due to an alarming number of complications associated with the device. The ProteGen Vaginal Sling was developed to treat patients who suffer from urinary stress incontinence. Urologists implant the device under the bladder. Unfortu